- Unexpected Results of Induction Chemotherapy vs Adjuvant Chemotherapy—Reply
- Artificial Intelligence–Detected Tumor-Infiltrating Lymphocytes and Outcomes in Anti–PD-1–Based Treated Melanoma
- Contraceptive Choices and Breast Cancer Risk
- Rethinking End Points in Modern Oncology Trials—Beyond the P Value
- Do All Breast Cancer Survivors Need to See a Cardiologist?
- Error in Byline and Funding Section
- Intensification of Salvage Radiotherapy After Radical Prostatectomy
- Duffy Null–Associated Absolute Neutrophil Counts and Cancer Clinical Trial Eligibility
- Immune Checkpoint Inhibitors as Independent and Synergistic Drivers of SJS/TEN
- Trends in Dexrazoxane and Cardiovascular Health Care Use for Children With AML
- Rethinking End Points in Modern Oncology Trials—Beyond the P Value
- Limitations in Quantitative Harm-Benefit Assessment in Immuno-Oncology
- Long-Term Physical Activity for Prevention of Digestive System Cancers
- Power Limits in Body Mass Index, Activity, and Cancer Risk
- Muscle Mass, Fragility, Weight Loss, and Cancer Treatment
